TNXP

Latest SEC Filings & News for TNXP

2 most recent filings and news items mentioning TNXP. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/TNXP/news?limit=20"

Pull TNXP filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Tonix Pharmaceuticals Secures Second GPO Agreement for TONMYA, Expanding Coverage to 52M Lives

Tonix Pharmaceuticals announced a second commercial payer agreement effective June 1, 2026, adding approximately 17 million U.S. lives in coverage for its fibromyalgia drug TONMYA, bringing total commercial coverage to ~52 million lives (29% of U.S. commercial market). The milest

View filing at SEC.gov →

Tonix Pharmaceuticals publishes Phase 1 data for TNX-1500 anti-CD40L antibody

Tonix announced publication of Phase 1 clinical data for TNX-1500 in the Journal of Clinical Immunology, showing the drug was well-tolerated with favorable safety profile. A Phase 2 investigator-initiated kidney transplant study at Massachusetts General Hospital is expected to be

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.